High-Dose vitamin D3 does not provide benefit for metastatic colorectal cancer

SOLARIS trial: High-dose vitamin D3 added to standard chemotherapy plus bevacizumab for metastatic colorectal cancer showed no additional toxicity but did not delay cancer progression more than standard-dose vitamin D3. Potential benefit observed for left-sided disease, requiring further investigation.